Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial
about
Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeksComparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis.Significance of image guidance to clinical outcomes for localized prostate cancerSalvage low-dose-rate (125)I partial prostate brachytherapy after dose-escalated external beam radiotherapy.Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancerThe impact of dose-escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomograms.Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer.Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study.Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer.Radiation treatment for patients with intermediate-risk prostate cancer.Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy.Moderate hypofractionated radiotherapy is more effective and safe for localized prostate cancer patients: a meta-analysisAssessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complicatiDose gradient impact on equivalent dose at 2 Gy for high dose rate interstitial brachytherapy.The impact of trainee involvement on outcomes in low-dose-rate brachytherapy for prostate cancer.Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysisHypofractionated external-beam radiotherapy for prostate cancer.Particle therapy in prostate cancer: a review.Reducing biochemical recurrence rates in EBRT-treated prostate cancer patients: the influence of dose and dose per fraction.Post-radiotherapy prostate biopsies reveal heightened apex positivity relative to other prostate regions sampledRandomized trial of hypofractionated external-beam radiotherapy for prostate cancer.Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer.Systematic review of hypofractionated radiation therapy for prostate cancer.Positional reproducibility and effects of a rectal balloon in prostate cancer radiotherapy.A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant.Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials.Hypofractionated radiotherapy for localized prostate cancer.Does family history of prostate cancer affect outcomes following radiotherapy?Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis.Technological advances in radiation therapy for prostate cancer.Stereotactic body radiation therapy for prostate cancer.What do we know about the α/β for prostate cancer?Hypofractionated radiotherapy in prostate cancer.Hypofractioned radiotherapy in prostate cancer: is it the next step?Hypofractionated radiotherapy for prostate cancer.Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer.Hypofractionated helical tomotherapy (75 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term analysis of gastrointestinal and genitourinary toxicity.Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer.[External beam radiotherapy in the treatment of prostate cancer].Reducing radiation-associated toxicity using online image guidance (IGRT) in prostate cancer patients undergoing dose-escalated radiation therapy.
P2860
Q33613649-C3BBA248-8E81-4465-9760-DFEB28F121E7Q33626084-E8F88929-6795-4F79-A331-B32862C49B34Q33993238-D1403856-4838-4154-9551-4DA4ED4026F5Q34355171-B5AA1A38-3661-42AA-8B7E-66299BB64465Q35115736-2FDD0FDA-E498-4083-86F7-F5B23E9B8D62Q35141519-92CDCAB6-4425-4F92-BEB0-C4E2230FAABFQ35530488-D92D287F-DE04-44CC-B735-E5714D3D6830Q35981267-9B41063D-215F-40EA-ABB2-4AD8856239ECQ35985620-15A5D4F7-AA1B-4F67-94DD-05BA93AA0CD4Q35992830-7FF368F8-6FA6-47DD-AF33-836031EFB509Q36177201-0B501538-696A-45C8-82CC-BACA8371C2D6Q36214859-BB0F6997-EB26-43EE-A5D7-E64A736C4078Q36235453-DD1EDB4C-072C-48C6-B6F6-4BD48EDF7224Q36551293-D1706CC4-9F82-4B2E-8C87-B33F23F9BEF5Q36680127-475F18B1-95DB-4E30-8FCE-17FB6FA5550EQ36680259-07A2E1B2-F221-4E5B-A356-998E5D39794BQ36711751-020B5DF9-A7C0-47EC-8ACB-865463F2A4BBQ36847567-4282A8C5-39CB-4C27-B191-C3F847935FD2Q37016012-5AB83B05-429E-4F9D-9049-04CF660EE162Q37040609-5FF1239F-73B3-4F25-9645-5B9D2D2F0DA4Q37249348-0E2DB1E1-1D85-4B27-A742-697F6791A89AQ37308234-6F6EBC6C-B1B3-486B-8013-5E18CFEF4E37Q37324126-C526D245-49E8-40A9-BE92-701BF6453696Q37364546-B2BAE690-E479-44CF-AC66-6BEF7247DFCBQ37389902-5A531452-0606-405A-B42E-AE26CFFB51F0Q37539431-8FDDEBCF-70D6-4644-810B-D12821C8DAB6Q37547386-57BEF950-BB7D-4FE5-A119-1533648E0FE0Q37709661-F442D085-BCCF-4987-8248-9431484347AAQ37725623-B0D633B1-A4D8-47E2-9C73-4B12D278F1ECQ37738793-8FFE8EC2-CF29-4EEC-BFFF-591093E973E8Q37932543-7C5466BA-E0C5-4074-87EB-4A099F62D571Q38023478-6CDF52FC-2A26-4BDA-B7DF-B2F98E01497BQ38030596-F73D43D2-39FB-4EDD-8621-5C5C33F93AA3Q38264783-33DFF7D6-21AC-42F5-A25B-106CC4BD430BQ38283897-E35ADD1C-60B8-41C3-95C9-C9FFDF6D0FBDQ38603388-71D39FB2-76D2-4DD7-9E12-26EDCBAEC58AQ38746814-6E020CC1-D6F2-4E93-BEF9-498204276D07Q38937777-6383C4FE-64B6-4932-97BC-6D0C830C3763Q39239309-82EF4C22-AFC7-484E-BF3E-360D0BE3198EQ39415628-8BD9467A-203C-4935-94B8-7192CE4490B1
P2860
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Dosimetry and preliminary acut ...... ionation dose escalation trial
@ast
Dosimetry and preliminary acut ...... ionation dose escalation trial
@en
type
label
Dosimetry and preliminary acut ...... ionation dose escalation trial
@ast
Dosimetry and preliminary acut ...... ionation dose escalation trial
@en
prefLabel
Dosimetry and preliminary acut ...... ionation dose escalation trial
@ast
Dosimetry and preliminary acut ...... ionation dose escalation trial
@en
P2093
P2860
P1476
Dosimetry and preliminary acut ...... ionation dose escalation trial
@en
P2093
Alan Pollack
Alexandra L Hanlon
Andre A Konski
Benjamin Movsas
C-M Charlie Ma
Eric M Horwitz
Mark K Buyyounouski
Richard E Greenberg
Robert A Price
Robert G Uzzo
P2860
P304
P356
10.1016/J.IJROBP.2005.07.970
P407
P577
2005-10-19T00:00:00Z